Thursday, August 23, 2018

PHARMACOEPIDEMIOLOGY 2019

About Conference


ME Conferences is delighted and cordially welcomes you to attend the 12th International Conference on Pharmacoepidemiology and Clinical Research to be held during March 18-19, 2019 in Dubai, UAE. ME Conferences is an open resource platform that conducts 3000+ international events which includes International Conferences, Workshops, Symposia, Trade Shows, Exhibitions and Scientific Conferences in all major disciplines like Clinical, Medical, Pharmaceutical, Engineering, Technology, Business Management and Life Sciences across America, Europe, Middle East, and Asia Pacific. The events are gathering over twenty five million researchers, scholars, students, professionals and industrial personnel throughout the world. World Famous Scientists, Researchers, Academic and business delegates, young scientists and students in their individual fields grace our events as keynote speakers, plenary speakers, poster presenters, and organizing committee members.

Why to Attend???

12th International Conference on Pharmacoepidemiology and Clinical Research scheduled during March 18-19, 2019 in Dubai, UAE is organised aiming to bring together leading academic professors, scientists, researchers and students to exchange, share their experiences and research results on all aspects of Pharmacoepidemiology and Clinical research . It also provides a premier interdisciplinary pavement for Pharma, Regulatory, Drug Designing and clinical trial industries to represent their technological innovations and discuss the most recent approaches, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacoepidemiology & Clinical research.

Pharmaceutical research provides a profitable business opportunity to several pharmaceutical and biotech companies as these technologies have wide application areas such as drug discovery and research followed by New drug delivery systems.  Pharmacoepidemiology is the study of the utilization and effects of drugs in large numbers of people; it provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects. It can be called a bridge science spanning both clinical pharmacology and epidemiologyPart of the task of clinical pharmacology is to provide a risk benefit assessment by effects of drugs in patients:

1. Doing the studies needed to provide an estimate of the probability of beneficial effects on populations,

2. Or assessing the probability of adverse effects on populations.

Pharmacoepidemiology concentrates on clinical patient outcomes from therapeutics by using methods of clinical epidemiology and applying them to understanding the determinants of beneficial and adverse drug effects, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions, and the effects of medication non-adherence. Pharmacovigilance is a part of pharmacoepidemiology that involves continual monitoring, in a population, for unwanted effects and other safety concerns arising in drugs that are already on the market. Pharmacoepidemiology sometimes also involves the conduct and evaluation of programmatic efforts to improve medication use on a population basis. 

Epidemiology is the study of the distribution and determinants of diseases and other health states in populations. Epidemiological studies can be divided into two main types:

1.   Descriptive epidemiology describes disease and/or exposure and may consist of calculating rates, e.g., incidence and prevalence. Such descriptive studies do not at this time use health control groups and can only generate hypotheses,but not test them. Studies of drug use would generally fall under descriptive studies.

2.   Analytic epidemiology includes two types of studies: observational studies, such as case-control and cohort studies, and experimental studies which include clinical trials or randomized clinical trials. The analytic studies compare an exposed group with a control group and usually designed as hypothesis testing by studies.

Pharmacoepidemiology and Clinical research Congress includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and B2B(Business to Business) interactions.

Mark your dates to meet the experts & join the critical discussions at Pharmacoepidemiology and Clinical Research Congress scheduled during March 18-19, 2019 in Dubai, UAE. Register now to unleash Advanced Clinical research and compliance in the arena of Pharmacoepidemiology.

Who Should Attend??

Directors,Senior Directors,Executive Directors and Vice Presidents and Senior Vice Presidents, Executive Vice Presidents and Heads/Leaders/Partners of:


  • CROs and CMOs
  • Clinical Research Sites
  • Pharma/Biotech and Medical Device industries
  • Hospitals, Associations
  • Medical Advisors
  • Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians. University Faculties like Directors, Senior Professors and Assistant Professors and Associate Professor, Research Scholars, Adepts scientists who are related to clinical and medical research.

Clinical and Pharmaceutical and biotech industry professionals with responsibilities in:

  • Clinical Research & Development 
  • Clinical Design/ Protocol Design/ Clinical Strategy
  • Global Clinical Operations
  • Clinical Outsourcing 
  • Biostatistics/Data management
  • Patient Recruitment/Enrollment 
  • Clinical Trial Management
  • Clinical Trial Supplies
  • Regulatory Affairs

Conference Highlights



Special Issues


  •  All accepted abstracts will be published in respective Supported International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: https://pharmacoepidemiology.pharmaceuticalconferences.com/


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)